Authors: MYERS DE SICHENEDER A CLEMENTSON D DVORAK N VENKATACHALAM T SEV AR CHANDANLANGLIE M UCKUN FM

Citation: De. Myers et al., LARGE-SCALE MANUFACTURING OF B43(ANTI-CD19)-GENISTEIN FOR CLINICAL-TRIALS IN LEUKEMIA AND LYMPHOMA, Leukemia & lymphoma, 29(3-4), 1998, pp. 329

Authors: MYERS DE JUN X CLEMENTSON D DONELSON R SICHENEDER A HOFFMAN N BELL K SARQUIS M LANGLIE MC TURNER N UCKUN FM

Citation: De. Myers et al., LARGE-SCALE MANUFACTURING OF TXU(ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN(PAP) IMMUNOCONJUGATE FOR CLINICAL-TRIALS, Leukemia & lymphoma, 27(3-4), 1997, pp. 275-302

Authors: GUNTHER R CHELSTROM LM WENDORF HR SCHNEIDER EA COVALCIUC K JOHNSON B CLEMENTSON D IRVIN JD MYERS DE UCKUN FM

Citation: R. Gunther et al., TOXICITY PROFILE OF THE INVESTIGATIONAL NEW BIOTHERAPEUTIC AGENT, B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Leukemia & lymphoma, 22(1-2), 1996, pp. 61